Perinatal mortality and severe maternal morbidity among individuals with hypertensive disorders of pregnancy (HDP) are often driven by persistent, uncontrolled hypertension. Whereas traditional perinatal blood pressure (BP) ascertainment occurs through in-person clinic appointments, self-measured blood pressure (SMBP) programs allow individuals to measure their BP remotely and receive remote management by a medical team. Though data remain limited on clinically important outcomes such as maternal morbidity, these programs have shown promise in improving BP ascertainment rates in the immediate postpartum period and enhancing racial and ethnic equity in BP ascertainment after hospital discharge. In this narrative review, we provide an overview of perinatal SMBP programs that have been described in the literature and the data that support their efficacy. Furthermore, we offer suggestions for practitioners, institutions, and health systems that may be considering implementing SMBP programs, including important health equity concerns to be considered. Last, we discuss opportunities for ongoing and future research regarding SMBP programs' effects on maternal morbidity, long-term health outcomes, inequities that are known to exist in HDP and HDP-related outcomes, and the cost effectiveness of these programs.

中文翻译：

---

围产期远程血压监测。


妊娠期高血压疾病 (HDP) 患者的围产期死亡率和严重孕产妇发病率通常是由持续且不受控制的高血压造成的。传统的围产期血压 (BP) 确定是通过现场诊所预约进行的，而自我测量血压 (SMBP) 程序允许个人远程测量血压并接受医疗团队的远程管理。尽管关于孕产妇发病率等临床重要结果的数据仍然有限，但这些计划在提高产后立即血压确定率以及提高出院后血压确定的种族和民族公平性方面显示出了希望。在这篇叙述性综述中，我们概述了文献中描述的围产期 SMBP 计划以及支持其功效的数据。此外，我们还为可​​能考虑实施 SMBP 计划的从业者、机构和卫生系统提供建议，包括需要考虑的重要健康公平问题。最后，我们讨论了正在进行和未来研究的机会，这些研究涉及 SMBP 计划对孕产妇发病率的影响、长期健康结果、HDP 和 HDP 相关结果中已知存在的不平等，以及这些计划的成本效益。